Optimization of expression vector design for enhanced recombinant protein production in mammalian cell systems

Introduction

Recombinant protein production in mammalian cells has become essential for generating biotherapeutics, research reagents, and diagnostic tools with authentic post-translational modifications [1] . The United Kingdom maintains a strong position in biopharmaceutical research and manufacturing, with substantial investment in protein production technologies at academic institutions and industrial facilities [2] . Optimizing the efficiency of mammalian expression systems directly impacts both research productivity and manufacturing economics. Expression vectors serve as the primary determinant of transgene expression levels, with multiple elements contributing to overall productivity including promoters, enhancers, introns, polyadenylation signals, and mRNA stabilizing sequences [3] . The selection and optimization of these components can dramatically influence protein yields, yet systematic comparisons across commonly used elements remain limited in the published literature [4] . Understanding the quantitative contribution of individual vector elements enables rational design approaches for specific applications. This research conducted comprehensive evaluation of expression vector components using standardized reporter assays and recombinant protein production experiments [5] . The experimental design employed parallel comparison of promoters, mRNA stabilizing elements, and codon optimization strategies to identify optimal combinations for mammalian cell expression. These findings establish an improved vector platform with broad applicability for British and international research and biopharmaceutical communities.

Material and Methods

Vector Construction

Expression vectors were constructed using standard molecular cloning techniques with Gibson Assembly for seamless element insertion. Promoter sequences (CMV, EF1α, CAG, SV40, UBC, PGK) were amplified from validated template plasmids and cloned upstream of a standardized multiple cloning site. The WPRE element was inserted downstream of the transgene stop codon. Codonoptimized sequences were synthesized commercially using human codon usage tables. All constructs were verified by complete sequencing.

Cell Culture and Transfection HEK293, CHO-K1, HeLa, Cos-7, and NIH3T3 cells were maintained in appropriate media under standard conditions (37 °C, 5% CO2). Transient transfections were performed using polyethylenimine at optimized DNA:reagent ratios. Transfection efficiency was normalized using co-transfected Renilla luciferase controls. Stable pools were generated using appropriate selection markers and maintained under selective pressure.

Protein Quantification

Reporter gene assays employed firefly luciferase with dualluciferase normalization. Recombinant protein production was quantified by ELISA and confirmed by Western blotting. Protein yields were calculated based on culture volume and expressed as mg/L. All experiments included minimum three biological replicates with technical triplicates.

Results

Promoter comparison revealed substantial differences in expression strength across the tested elements. The CAG promoter demonstrated the highest activity at 124.6% relative to CMV, while SV40 showed the lowest at 42.3%. The commonly used EF1α promoter achieved 87.4% of CMV levels.

Discussion

This systematic evaluation demonstrates that rational vector design can substantially improve recombinant protein yields in mammalian cells. The 1.8-fold improvement achieved through combined optimization represents a meaningful advance for both research and manufacturing applications. The consistency of improvement across multiple cell lines suggests broad applicability of these design principles. The superior performance of the CAG promoter likely reflects its hybrid design incorporating the CMV enhancer with chicken β-actin promoter elements, providing both strong basal activity and reduced susceptibility to silencing [6] . The contribution of WPRE to expression enhancement presumably results from improved mRNA stability and nuclear export efficiency. Codon optimization addresses translational efficiency by matching codon usage to highly expressed human genes.

These optimized vectors have been made available through institutional repositories and represent a valuable resource for the British biotechnology community. The systematic approach employed in this research provides a template for future optimization efforts targeting specific production applications or alternative host cell systems.

Conclusion

This research establishes an optimized expression vector platform achieving significantly enhanced protein production in mammalian cells. The systematic comparison of vector elements provides quantitative guidance for rational vector design. These findings support continued investment in expression technology development and provide practical tools for academic and industrial protein production applications.

Acknowledgement

AcknowledgementsThis research was supported by the Wellcome Trust (grant 204826/Z/16/Z) and the Biotechnology and Biological Sciences Research Council (BB/R018049/1). The authors acknowledge the Oxford Protein Production Facility for technical support.

References

1. Lalonde ME, Bhardwaj S. Therapeutic proteins and antibody production in mammalian cells. Biotechnology and Bioengineering. 2017;114(5):959976.
2. Owczarek B, et al. UK biopharmaceutical manufacturing: current landscape and future directions. Drug Discovery Today. 2019;24(9):1813-1819.
3. Kim JY, et al. CHO cells in biotechnology for production of recombinant proteins. Applied Microbiology and Biotechnology. 2012;93(3):917-930.
4. Chin CL, et al. A human expression system based on HEK293 for the stable production of recombinant erythropoietin. Scientific Reports. 2019;9(1):16768.
5. Aricescu AR, et al. A time-and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallographica Section D. 2006;62(10):12431250.
6. Miyazaki J, et al. Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5. Gene. 1989;79(2):269-277.